Abstract
Oligophrenin-1 regulates dendritic spine morphology in the brain. Mutations in the oligophrenin-1 gene (OPHN1) cause intellectual disability. We discovered a previously unknown partner of oligophrenin-1, Rev-erbα, a nuclear receptor that represses the transcription of circadian oscillators. We found that oligophrenin-1 interacts with Rev-erbα in the mouse brain, causing it to locate to dendrites, reducing its repressor activity and protecting it from degradation. Our results indicate the presence of a circadian oscillator in the hippocampus, involving the clock gene Bmal1 (also known as Arntl), that is modulated by Rev-erbα and requires oligophrenin-1 for normal oscillation. We also found that synaptic activity induced Rev-erbα localization to dendrites and spines, a process that is mediated by AMPA receptor activation and requires oligophrenin-1. Our data reveal new interactions between synaptic activity and circadian oscillators, and delineate a new means of communication between nucleus and synapse that may provide insight into normal plasticity and the etiology of intellectual disability.
© 2011 Nature America, Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
ARNTL Transcription Factors / genetics
-
ARNTL Transcription Factors / metabolism
-
Analysis of Variance
-
Animals
-
Bicuculline / pharmacology
-
Cells, Cultured
-
Cerebral Cortex / cytology
-
Chlorocebus aethiops
-
Circadian Clocks / genetics
-
Circadian Clocks / physiology*
-
Cysteine Proteinase Inhibitors / pharmacology
-
Cytoskeletal Proteins / deficiency
-
Cytoskeletal Proteins / genetics
-
Cytoskeletal Proteins / metabolism*
-
Dendrites / metabolism
-
Drug Interactions
-
Embryo, Mammalian
-
Excitatory Amino Acid Antagonists / pharmacology
-
GABA-A Receptor Antagonists / pharmacology
-
GTPase-Activating Proteins / deficiency
-
GTPase-Activating Proteins / genetics
-
GTPase-Activating Proteins / metabolism*
-
Gene Expression Regulation / genetics
-
Green Fluorescent Proteins / genetics
-
Hippocampus / cytology*
-
Humans
-
Immunoprecipitation
-
Leupeptins / pharmacology
-
Mice
-
Mice, Knockout
-
Mutation / genetics
-
Neurons / cytology
-
Neurons / drug effects
-
Neurons / physiology*
-
Nuclear Proteins / deficiency
-
Nuclear Proteins / genetics
-
Nuclear Proteins / metabolism*
-
Nuclear Receptor Subfamily 1, Group D, Member 1 / genetics
-
Nuclear Receptor Subfamily 1, Group D, Member 1 / metabolism*
-
Quinoxalines / pharmacology
-
RNA, Messenger / metabolism
-
RNA, Small Interfering / pharmacology
-
Rats
-
Sodium Channel Blockers / pharmacology
-
Tetrodotoxin / pharmacology
-
Time Factors
-
Transfection / methods
-
Two-Hybrid System Techniques
-
Valine / analogs & derivatives
-
Valine / pharmacology
Substances
-
ARNTL Transcription Factors
-
Cysteine Proteinase Inhibitors
-
Cytoskeletal Proteins
-
Excitatory Amino Acid Antagonists
-
GABA-A Receptor Antagonists
-
GTPase-Activating Proteins
-
Leupeptins
-
NR1D1 protein, human
-
Nuclear Proteins
-
Nuclear Receptor Subfamily 1, Group D, Member 1
-
OPHN1 protein, human
-
Quinoxalines
-
RNA, Messenger
-
RNA, Small Interfering
-
Sodium Channel Blockers
-
2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
-
Green Fluorescent Proteins
-
Tetrodotoxin
-
2-amino-5-phosphopentanoic acid
-
Valine
-
benzyloxycarbonylleucyl-leucyl-leucine aldehyde
-
Bicuculline